Fulcrum Therapeutics Inc (FULC) Stock Price, Quote, News & History

FULCNASDAQ
$3.77
0.071.89%
Last update: Jun 22, 7:41 PM
$3.65
-0.05-1.35%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-63.56M
Investing Cash Flow (TTM)
-96.71M
Financing Cash Flow (TTM)
168.36M
Free Cash Flow (TTM)
-63.88M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
8.08M

Analyst Trends and Forecast

1
Jan
2
2
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
2.5
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$80.91M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.74
Earnings Yield % (TTM)
-31.12%
Earnings Yield % (FWD)
-27.88%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.00

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$50.26M
Debt to Equity
0.02
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$3.69
Close
$3.77
Volume / Avg.
2.87M / 2.05M
Day Range
$3.63 - $3.89
52 Wk Range
2.83 - 15.74
Market Cap
$243.21M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
32
Short Interest
15.99%
Days to Cover
19.81

About

Sector
Health Care
Industry
Pharmaceuticals
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Fulcrum Therapeutics (FULC) stock?

A

You can purchase shares of Fulcrum Therapeutics (NASDAQ:FULC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Fulcrum Therapeutics (FULC) competitors?

A

There are no as such competitors for Fulcrum Therapeutics.

Q

What is the forecast, or price target, for Fulcrum Therapeutics (FULC) stock?

A

Fulcrum Therapeutics has a consensus price target of $8.00.

Q

What is the current price for Fulcrum Therapeutics (FULC)?

A

The stock price for Fulcrum Therapeutics (NASDAQ: FULC) is $3.65 last updated June 22, 2026 at 7:41 PM EDT.

Q

Does Fulcrum Therapeutics (FULC) pay a dividend?

A

There are no upcoming dividends for Fulcrum Therapeutics.

Q

When is Fulcrum Therapeutics (NASDAQ:FULC) reporting earnings?

A

Fulcrum Therapeutics does not have any upcoming earnings scheduled.

Q

Is Fulcrum Therapeutics (FULC) going to split?

A

There is no upcoming split for Fulcrum Therapeutics.

Q

What sector and industry does Fulcrum Therapeutics (FULC) operate in?

A

Fulcrum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.